Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2026-01-21 @ 7:35 PM
Study NCT ID:
NCT03364868
Status:
COMPLETED
Last Update Posted:
2024-10-08
First Post:
2017-11-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)
Sponsor:
Technical University of Munich
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GPPAD-03-POInT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None